SEM
TELO icon

Suncoast Equity Management’s Telomir Pharmaceuticals TELO Stock Holding History

Suncoast Equity Management’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51,194
Closed -$66.6K – 101
2026
Q1 		$66.6K Hold
51,194
– – 0.01% 93
2025
Q4 		$68.1K Hold
51,194
– – 0.01% 89
2025
Q3 		$71.2K Hold
51,194
– – 0.01% 88
2025
Q2 		$64K Hold
51,194
– – 0.01% 84
2025
Q1 		$165K Hold
51,194
– – 0.02% 78
2024
Q4 		$211K Hold
51,194
– – 0.02% 73
2024
Q3 		$329K Buy
51,194
+26,803
+110% +$131K 0.04% 64
2024
Q2 		$117K Hold
24,391
– – 0.01% 67
2024
Q1 		$126K Buy
+24,391
New +$184K 0.01% 68

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return

Suncoast Equity Management's TELO Position: Q2 2026 in Review

Suncoast Equity Management sold out of Telomir Pharmaceuticals (TELO) in Q2 2026, closing a stake of 51,194 shares — an estimated $66.6K sold.

Suncoast Equity Management first reported a position in TELO in Q1 2024 and held it in 9 quarters. The position peaked at $329K in Q3 2024. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Suncoast Equity Management reported no remaining Telomir Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Suncoast Equity Management sold 51,194 Telomir Pharmaceuticals shares in Q2 2026, an estimated $66.6K.
  • Suncoast Equity Management first reported a position in Telomir Pharmaceuticals in Q1 2024 and held it in 9 quarters.
  • Suncoast Equity Management's Telomir Pharmaceuticals position peaked at $329K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Suncoast Equity Management's 13F filing for Q2 2026, filed 4 Aug 2026.